So with a predicted revenue for CY24 for Daybue being $370m-$420m and the first quarter predicted at $80m it would seem that these figures may indicate quarterly growth of 10-15% with $95m, $115m and $130m taking figures up to $420m
If we use the lower end of growth at 10% for year 2025 we would get
Q1 $100m
Q2 $140m
Q3 $155m
Q4 $170m
or totalling ~ $550m and the trigger of another $50m milestone payment
Also 2025 should see some revenue flow from Canada
Not bad year on year revenue where it would seem various milestone triggers will complement royalties for a few years to come
- Forums
- ASX - By Stock
- NEU
- Ann: 2023 Results webinar
NEU
neuren pharmaceuticals limited
Add to My Watchlist
7.26%
!
$13.45

Ann: 2023 Results webinar, page-46
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.45 |
Change
0.910(7.26%) |
Mkt cap ! $1.692B |
Open | High | Low | Value | Volume |
$12.96 | $14.00 | $12.91 | $15.99M | 1.168M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 79 | $13.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.46 | 114 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 484 | 13.410 |
4 | 268 | 13.400 |
3 | 909 | 13.390 |
3 | 831 | 13.380 |
4 | 399 | 13.370 |
Price($) | Vol. | No. |
---|---|---|
13.450 | 203 | 2 |
13.460 | 492 | 4 |
13.470 | 996 | 6 |
13.480 | 1202 | 5 |
13.490 | 1353 | 4 |
Last trade - 15.22pm 26/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online